Health ❯ Research

Clinical Research

Cancer Research Drug Development Trial Results Epidemiology Diabetes Research Observational Studies Proteomics Genetic Research Biomarkers Preclinical Studies

Antidepressant Fluvoxamine Eases Long COVID Fatigue in Randomized Trial

The results suggest a practical, low-cost option pending confirmation.

Androgen Signaling Drives Lethal Pediatric Ependymoma, Study Finds

Repurposed Epilepsy Drug Cuts Sleep Apnea Events by Up to 47% in Phase II Trial

MHRA Approves Leqselvi for Severe Alopecia Areata in Adults

Ketogenic Diet Yields Modest Six‑Week Relief in Drug‑Resistant Depression

ISS Study Finds Microgravity Reshapes Phage–Bacteria Evolution, Boosting Activity Against Drug-Resistant E. coli

UC San Diego Team Unveils Three-Hit Metabolic Model for Autism

First New Antimalarial in Decades Tops 97% Cure in Phase III as Novartis Seeks Approval

Merck’s Oral PCSK9 Pill Matches Injectables in Phase 3, Setting Up 2026 FDA Bid

Alzheimer’s Social Memory Loss Linked to Perineuronal Net Breakdown in Mice

Early Stem Cell Infusion After First Heart Attack Cuts Heart Failure Risk in Phase 3 Trial

mRNA COVID Vaccination Linked to Longer Survival With Cancer Immunotherapy, Data Presented at ESMO

Nobel in Medicine Honors Brunkow, Ramsdell and Sakaguchi for Immune Tolerance Breakthrough

Mouse Eye Imaging Reveals Early Immune Activity in Diabetic Retinopathy

Wearable HRV Patch Cut Daily Substance Use 64% in Phase II Trial

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial

Common Genetic Variant Skews HbA1c, Delaying Diabetes Diagnosis in Black and South Asian Men

Five-Year Follow-Up Finds 67% Remission After Psilocybin-Assisted Therapy

Long-Read Study Links Toddler Gut Microbiome Stability to Growth, Builds 986-Genome Library

Tumors Hijack Bone Marrow’s Iron, Explaining Anemia in Bone Metastasis